Your browser doesn't support javascript.
loading
Evaluation of a Comprehensive Skin Toxicity Program for Patients Treated With Epidermal Growth Factor Receptor Inhibitors at a Cancer Treatment Center.
Yu, Zizi; Dee, Edward Christopher; Bach, Daniel Q; Mostaghimi, Arash; LeBoeuf, Nicole R.
Affiliation
  • Yu Z; Harvard Medical School, Boston, Massachusetts.
  • Dee EC; Harvard Medical School, Boston, Massachusetts.
  • Bach DQ; Division of Dermatology, University of California, Los Angeles Medical Center, Santa Monica.
  • Mostaghimi A; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
JAMA Dermatol ; 156(10): 1079-1085, 2020 10 01.
Article in En | MEDLINE | ID: mdl-32609305

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer Care Facilities / Colorectal Neoplasms / Drug Eruptions / Guideline Adherence / Protein Kinase Inhibitors / Head and Neck Neoplasms Type of study: Etiology_studies / Evaluation_studies / Guideline / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged80 Country/Region as subject: America do norte Language: En Journal: JAMA Dermatol Year: 2020 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer Care Facilities / Colorectal Neoplasms / Drug Eruptions / Guideline Adherence / Protein Kinase Inhibitors / Head and Neck Neoplasms Type of study: Etiology_studies / Evaluation_studies / Guideline / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged80 Country/Region as subject: America do norte Language: En Journal: JAMA Dermatol Year: 2020 Document type: Article Country of publication: Estados Unidos